Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Board Changes

4 Jul 2023 07:01

RNS Number : 8882E
Restore PLC
04 July 2023
 

4 July 2023

 

Restore plc

 

("Restore" or the "Group" or "Company")

 

Board Changes

Restore plc (AIM: RST), the UK's leading provider of digital and information management and secure lifecycle services, announces that by mutual consent Charles Bligh will be standing down as Chief Executive Officer and Board Director and that Jamie Hopkins, Senior Independent Director, has agreed to become Interim Chief Executive Officer, both with immediate effect.

In addition, current Chair, Sharon Baylay-Bell, has agreed to become Executive Chair, also with immediate effect.

Jamie Hopkins has over 20 years of plc senior leadership experience and significant capital markets expertise. Jamie was CEO of Workspace Group plc (FTSE 250) between 2012 and 2019 where he delivered strong operational and financial performance, as well as leading significant growth and delivering business change.

Sharon Baylay-Bell is an experienced Chair of listed businesses and has been with Restore plc for eight years. Sharon combines detailed business and support services sector knowledge with an in-depth understanding of the Restore business.

Both Jamie and Sharon are fully committed to supporting the future success of Restore plc and maintaining value for the Company, its staff and other stakeholders.

Susan Davy, Audit Committee Chair and non-executive director will become the Senior Independent Director and Lisa Fretwell, Risk Committee Chair and non-executive director, will become Chair of the Remuneration Committee, both with immediate effect.

An executive search process for a replacement CEO will be initiated also with immediate effect.

The Board would like to thank Charles for the contribution he has made over the last four years and wishes him well for the future.

 

 

 

For further information please contact:

Restore plc www.restoreplc.com

Jamie Hopkins, Interim CEO +44 (0) 207 409 2420

Sharon Baylay-Bell, Executive Chair

Neil Ritchie, CFO

Chris Fussell, Company Secretary

 

Investec (Nominated Adviser and Joint Broker) www.investec.com

Carlton Nelson +44 (0) 207 597 5970

James Rudd

 

Canaccord Genuity (Joint Broker, Corporate Advisor)  www.canaccordgenuity.com

Max Hartley +44 (0) 207 523 8000

Chris Robinson

 

Citi (Joint Broker) www.citigroup.com

Stuart Field +44 (0) 207 986 4074

Laura White

 

Buchanan Communications (PR Enquiries) www.buchanan.uk.com

Charles Ryland +44 (0) 207 466 5000

Simon Compton

 

Note:

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFIFSEDIISIIV
Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.